NCT04496544View on ClinicalTrials.gov

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)

CompletedOBSERVATIONAL
Enrollment

168,553

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 19, 2024

Study Completion Date

June 30, 2024

Conditions
Peripheral Arterial DiseasePaclitaxel Adverse ReactionSafety Issues
Interventions
OTHER

Retrospective data collection

No intervention; retrospective data collection

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Philips Healthcare

INDUSTRY

collaborator

Bard Peripheral Vascular, Inc.

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Cook Medical

UNKNOWN

lead

Beth Israel Deaconess Medical Center

OTHER

NCT04496544 - Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) | Biotech Hunter | Biotech Hunter